← All trials
NCT06832176
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 20, 2025
- Primary completion
- Jan 1, 2030
- Completion date
- Jul 1, 2030
- First posted
- Feb 18, 2025
- Last posted
- Feb 18, 2025
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Nanjing Medical UniversityLead sponsor
- Nanjing Medical UniversitySponsor investigator
- Nanjing Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.